인쇄하기
취소

Will Pfizer and BMS work on the revival of Eliquis?

Published: 2015-05-27 11:50:55
Updated: 2015-05-27 11:50:55

Co-marketing, joint operation or joint cultivation may lead to an immediate failure once cooperative companies start to consider it as a task of the other. In this context, outstanding multinational pharmaceutical companies in Korea, Pfizer and BMS, pushed forward with co-marketing of the next generation anticoagulant ‘Eliquis(generic name: apixaban),’ but the result was estimated to be poor la...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.